Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)

Market Cap	9.48B
Revenue (ttm)	6.11B
Net Income (ttm)	405.91M
Shares Out	898.67M
EPS (ttm)	0.45
PE Ratio	23.52
Forward PE	n/a
Dividend	0.13 (1.25%)
Ex-Dividend Date	Dec 18, 2024

Volume	43,770,223
Average Volume	84,052,241
Open	10.52
Previous Close	10.55
Day's Range	10.18 - 10.54
52-Week Range	6.62 - 12.70
Beta	0.32
RSI	40.28
Earnings Date	Aug 22, 2025

About SHA:600789

Shandong Lukang Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in China. The company provides analgesics and antipyretics; gastrointestinal; endocrine; cardio-cerebrovascular; anti-infective; and other human formulation products. It offers human and veterinary active pharmaceutical ingredient; veterinary formulation; bio-pesticides; and amino acid. The company also exports its products to European Union, the United States, the United Kingdom, Russia, India, Brazil, Japan, and internationally. The company was formerly known as Jini...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1966
• Employees: 6,388
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600789

Financial Performance

In 2024, SHA:600789's revenue was 6.23 billion, an increase of 1.41% compared to the previous year's 6.15 billion. Earnings were 394.62 million, an increase of 60.30%.